Furthermore, USP37 knockdown sensitizes cancer cells to DNA-damaging agents in xenograft models, suggesting that the USP37–BLM axis may provide new therapeutic targets for overcoming chemo or radiotherapy resistance in breast cancer. The gene discussed is USP37; the disease is breast carcinoma.